Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples